North America Continous Glucose Monitoring System Market Forecast 2017-2025

North America Continous Glucose Monitoring System Market Forecast 2017-2025


The North America market for the CGMA is estimated to grow $ 9372.07 million by 2025 at CAGR of 34.05%. The forecast period of the CGMA market is from 2017 to 2025 and the base year deliberated for the market study is 2016. North America has a colossal market share of CGMS market. With an awareness of benefits of using continuous glucose monitoring systems, better healthcare infrastructure, accelerated incidences of diabetes due to a sedentary lifestyle and high healthcare expenditure are some of the factors leading to the market growth.

The diverse factors leading to the CGMS market are an augmented increase in the number of people suffering from diabetes, authorization of artificial pancreas, greater awareness, and improved healthcare infrastructure and ease of using CGMS devices.


The market is segmented by application, product type, and geography. There are diverse product types comprising CGMS including the transmitters and receivers, and the sensors. The Sensors are further segmented on the basis of holter type retrospective sensors, insulin pumps, non-invasive glucose sensors, minimally invasive glucose sensors and real-time sensors. The glucose monitors applications end-users include homes, hospitals, diagnostics and clinics.

High acceleration in the prevalence of diabetes, rising health awareness in developing countries, changes in lifestyle, sedentary lifestyle, the rise in the need of efficient and hassle-free monitoring of blood and the launch of an artificial pancreas are the market drivers for CGMS.

Hospitals have the largest market share in terms of the end-user segment. The highest CAGR is expected for Home healthcare as an end-user. High costing of continuous glucose monitoring systems, deficient reimbursement options, and stringent regulatory norms are the factors that are likely to restrain the market growth.


The major companies that are mentioned in CGMA market report are Medtronic Inc., Ypsomed AG, Novo Nordisk, Bayer AG Roche, Animas Corporation, Glysens Inc., Abbott Laboratories, Insulet Corporation, and Dexcom Inc.

1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study And Forecasting Years
1.3. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.2. Bottom-up Approach
2.3. Top Down Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary & Key Findings Of The Study
4. Market Overview
4.1. Drivers And Impact
4.1.1. Increase In Diabetic Population
4.1.2. Increase In Healthcare Expenditure
4.1.3. Increasing Focus On Research And Development
4.1.4. Technology Integration
4.1.5. Increasing Cgms Affordability
4.1.6. Low Price Of Technology
4.2. Restraint And Impact
4.2.1. Hinderance From Government Regulations
5. Cgms Market By Component Type
5.1. Sensors
5.2. Transmitters And Receivers
5.3. Insulin Pump
6. Cgms Market By Application
6.1. Home Settings
6.2. Diagnostics And Clinics
6.3. Hospitals
7. Key Analytical
7.1. 5 Forces Analysis
7.1.1. Threat Of New Entrant
7.1.2. Threat Of Substitute Products Or Services
7.1.3. Bargaining Power Of Buyers
7.1.4. Bargaining Power Of Supplier
7.1.5. Intensity Of Competitive Rivalry
7.2. Top Three Market Trends
7.2.1. Inadequate Reimbursement Options For Cgm
7.2.2. Lack Of Knowledge
7.2.3. Reduction Of Handling Efforts
7.3. Merger And Acquisitions
7.4. Key Trends
7.4.1. Development Of High-quality Wearable Devices
7.4.2. Mobile Healthcare Making The Devices More User-friendly
7.4.3. Increasing Efforts Towards Spread Of Awareness
7.4.4. Increase In Non-invasive Devices
7.4.5. Energy Harvesting Technology For Uninterrupted Usage
8. Regional Analysis
8.1. North America
8.1.1. The U.S Cgms Market
8.1.2. Canada Cgms Market
9. Competitive Landscape
9.1. Introduction
9.2. Medtronic
9.2.1. Business Profile
9.2.2. Product Portfolio
9.2.3. Revenue Analysis
9.2.4. Strategic Inputs
9.2.5. Scot Analysis
9.3. Dexcom
9.3.1. Business Profile
9.3.2. Product Portfolio
9.3.3. Revenue Analysis
9.3.4. Strategic Inputs
9.3.5. Scot Analysis
9.4. Abbott
9.4.1. Business Profile
9.4.2. Product Portfolio
9.4.3. Revenue Analysis
9.4.4. Strategic Inputs
9.4.5. Scot Analysis
9.5. Johnson And Johnson
9.5.1. Business Profile
9.5.2. Product Portfolio
9.5.3. Revenue Analysis
9.5.4. Strategic Inputs
9.5.5. Scot Analysis
9.6. Insulet Corp
9.6.1. Business Profile
9.6.2. Product Portfolio
9.6.3. Revenue Analysis
9.6.4. Strategic Inputs
9.6.5. Scot Analysis
9.7. Tandem Diabetes Care
9.7.1. Business Profile
9.7.2. Revenue Analysis
9.7.3. Product Portfolio
9.7.4. Strategies Inputs
9.7.5. Scot Analysis
9.8. Echo Therapeutics Inc
9.8.1. Business Profile
9.8.2. Revenue Analysis
9.8.3. Product Portfolio
9.8.4. Strategies Inputs
9.8.5. Scot Analysis
9.9. Roche Diagnostics
9.9.1. Business Profile
9.9.2. Revenue Analysis
9.9.3. Product Portfolio
9.9.4. Strategies Inputs
9.9.5. Scot Analysis
9.10. Nemaura Medical Inc
9.10.1. Business Profile
9.10.2. Revenue Analysis
9.10.3. Product Portfolio
9.10.4. Strategies Inputs
9.10.5. Scot Analysis
9.11. Senseonics Inc
9.11.1. Business Profile
9.11.2. Revenue Analysis
9.11.3. Product Portfolio
9.11.4. Strategies Inputs
9.11.5. Scot Analysis
9.12. Glysens Inc
9.12.1. Business Profile
9.12.2. Strategies Inputs
9.12.3. Product Portfolio
9.12.4. Scot Analysis
List Of Tables
Table 1 North America Cgms Market, 2017-2025(In $ Million)
Table 2 North America Cgms Market, By Component Type, 2017-2025(In $ Million)
Table 3 North America Cgms Sensors Market, 2017-2025(In $ Million)
Table 4 North America Cgms Transmitters And Receivers Market, 2017-2025(In $ Million)
Table 5 North America Cgms Insulin Pump Market, 2017-2025(In $ Million)
Table 6 North America Cgms Market, By Application 2017-2025 (In $ Million)
Table 7 North America Cgms Home Settings Market, 2017-2025(In $ Million)
Table 8 North America Cgms Diagnostics And Clinical Market, 2017-2025(In Us$ Million)
Table 9 North America Cgms Hospitals Market, 2017-2025(In $ Million)
List Of Figures
Figure 1 North America Cgms Market Share, By Component Type 2016 & 2025 (%)
Figure 2 North America Cgms Sensors Market, 2017-2025(In $ Million)
Figure 3 North America Cgms Transmitters And Receivers Market, 2017-2025(In $ Million)
Figure 4 North America Cgms Insulin Pump Market, 2017-2025(In $ Million)
Figure 5 North America Cgms Share, By Application 2016 & 2025(%)
Figure 6 North America Cgms Home Setting Market, 2017-2025(In $ Million)
Figure 7 North America Cgms Diagnostics And Clinical Market, 2017-2025(In $ Million)
Figure 8 North America Cgms Hospitals Market, 2017-2025(In $ Million)
Figure 9 North America Ggms Market Share, 2016 & 2025(%)
Figure 10 North America Cgms Market Share, By Country 2016 & 2025 (%)
Figure 11 Us Cgms Market Revenue, 2017-2025(In $ Million)
Figure 12 Canada Cgms Market Revenue, 2017-2025 (In $ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook